Matthew Galliher

Matthew Galliher is a scientist specializing in drug discovery at Cayman Chemical since December 2022. Prior to this role, Matthew was a graduate student at the University of Michigan from April 2016 to December 2022, where a Doctor of Philosophy (Ph.D.) in Chemistry was earned. Earlier, Matthew served as a tutor in organic chemistry at Washington State University from August 2014 to May 2016 and worked as a chemist at Cancer Targeted Technology during the summer of 2013, focusing on the synthesis and characterization of patented inhibitors and drug conjugates. Matthew holds both a Bachelor's Degree in Chemistry and Biochemistry from Washington State University, completed in 2015.